Glucose lowering therapeutic strategies for type 2 diabetic patients with chronic kidney disease in primary care setting in France: A cross-sectional study

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Grandfils, N ^a   Detournay, B ^b   Attali, C ^c   Joly, D ^d   Simon, D ^e,f   Verges B ^g   Toussi, M ^a   Briand, Y ^h   Delaitre, O ^h  

^a IQVIA   (United States)

^b CEMKA EVAL   (France)

^c Medical Office   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^g HÔPITAL DU BOCAGE   (France)

^h BOEHRINGER INGELHEIM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DATA BASE; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTRONIC MEDICAL RECORD; FEMALE; FRANCE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 84877276739     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/640632     Document Type: Article

References (23)

1. National Diabetes Statistics,. National Diabetes Information Clearinghouse [Internet], 2011, http://diabetes.niddk.nih.gov/dm/pubs/ statistics/
2. Ricci P., Blotiere P. O., Weill A., Simon D., Tuppin P., Ricordeau P., Diabète traité: quelles évolutions entre 2000 et 2009 en France? Bulletin Epidémiologique Hebdomadaire 2010 42-43 425 431
3. CNAMTS, Propositions de l'Assurance Maladie sur les charges et produits pour l'année 2013 [Internet]. Caisse Nationale d'Assurance Maladie des Travailleurs Salariés, 2012, http://www.ameli.fr
4. CDC,. National Chronic Kidney Disease Fact Sheet 2010-Factsheets- Publication-Diabetes DDT [Internet], http://www.cdc.gov/diabetes/pubs/ factsheets/kidney.htm
5. Radbill B., Murphy B., LeRoith D., Rationale and strategies for early detection and management of diabetic kidney disease. Mayo Clinic Proceedings 2008 83 12 1373 1381 2-s2.0-57349105118 10.4065/83.12.1373
6. Plantinga L. C., Crews D. C., Coresh J., Miller E. R. III, Saran R., Yee J., Hedgeman E., Pavkov M., Eberhardt M. S., Williams D. E., Powe N. R., Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clinical Journal of the American Society of Nephrology 2010 5 4 673 682 2-s2.0-77950930001 10.2215/CJN.07891109
7. Lok C. E., Oliver M. J., Rothwell D. M., Hux J. E., The growing volume of diabetes-related dialysis: a population based study. Nephrology Dialysis Transplantation 2004 19 12 3098 3103 2-s2.0-11244300812 10.1093/ndt/gfh540 (Pubitemid 40057634)
8. Ritz E., Rychlík I., Locatelli F., Halimi S., End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. The American Journal of Kidney Diseases 1999 34 5 795 808 2-s2.0-0032737294 (Pubitemid 29521694)
9. Lassalle M., Couchoud C., Réseau Epidémiologie et Information en Néphrologie [Internet]. Saint Denis: Agence de la Biomédecine, 2010, http://www.soc-nephrologie.org/REIN/documents.htm
10. KDOQI Guidelines [Internet]. http://www.kidney.org/professionals/KDOQI/ guidelines-commentaries.cfm
11. Ertel-Pau V., Raimond V., Stratégie médicamenteuse du contrôle glycémique du diabète de type 2. Médecine Thérapeutique 2012 18 1 41 53
12. Huang E. S., Liu J. Y., Moffet H. H., John P. M., Karter A. J., Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care 2011 34 6 1329 1336 10.2337/dc10-2377
13. Koro C. E., Lee B. H., Bowlin S. J., Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clinical Therapeutics 2009 31 11 2608 2617 2-s2.0-74549133127 10.1016/j.clinthera.2009.10.020
14. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. The New England Journal of Medicine 2004 351 13 1296 1305 2-s2.0-4644221457 10.1056/NEJMoa041031 (Pubitemid 39268908)
15. Assogba G. F. A., Couchoud C., Roudier C., Pornet C., Fosse S., Romon I., Druet C., Stengel B., Fagot-Campagna A., Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007). Diabetes and Metabolism 2012 38 6 558 566 10.1016/j.diabet.2012.08.004
16. Becher H., Kostev K., Schröder-Bernhardi D., Validity and representativeness of the "disease analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies. International Journal of Clinical Pharmacology 2009 47 10 617 626
17. Sharif A., Current and emerging antiglycaemic pharmacological therapies: the renal perspective. Nephrology 2011 16 5 468 475 2-s2.0-79959862459 10.1111/j.1440-1797.2011.01466.x
18. Oulahiane A., Anaddam S., Ouleghzal H., Elhaddad N., Moussaoui S., Yaagoubi N., Boufares F., Belmejdoub G., Diabetes management issues for patients with chronic kidney disease. Nephrologie and Therapeutique 2012 8 3 135 140
19. Islam T. M., Fox C. S., Mann D., Muntner P., Age-related associations of hypertension and diabetes mellitus with chronic kidney disease. BMC Nephrology 2009 10 1, article 17 2-s2.0-68949195891 10.1186/1471-2369-10-17
20. Bonnet F., Gauthier E., Gin H., Hadjadj S., Halimi J. M., Hannedouche T., Rigalleau V., Romand D., Roussel R., Zaoui P., Expert consensus on management of diabetic patients with impairment of renal function. Diabetes and Metabolism 2011 37 supplement 2 1 25
21. American Diabetes Association, Standards of Medical Care in Diabetes-2012. Diabetes Care 2012 35 supplement 1 S11 S63 10.2337/dc12-s011
22. Type 2 Diabetes-newer agents (partial update of CG66) [Internet]. http://guidance.nice.org.uk/CG87
23. Inzucchi S. E., Bergenstal R. M., Buse J. B., Diamant M., Ferrannini E., Nauck M., Peters A. L., Tsapas A., Wender R., Matthews D. R., Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American diabetes association (ADA) and the european association for the study of diabetes (EASD). Diabetologia 2012 55 6 1577 1596 10.1007/s00125-012-2534-0